Stem cell gene therapy - search results

The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.

The immune system is the body’s natural defence against antigens such as bacteria and viruses, but in some cases, it can malfunction. We explore the prevalence of immune system disorders, the associated unmet medical needs, and therapeutic research.

Age-related macular degeneration is known to affect millions of people around the globe and is fourth on the list of diseases that commonly lead to blindness, behind cataracts, preterm birth and glaucoma Macular degeneration, also called age-related macular degeneration (AMD), is a medical condition that results in blurred or total...

CorTec’s Brain Interchange™ system offers closed-loop neuromodulation, revolutionizing brain therapy by precisely adapting treatment based on individual needs.

The current primary treatment for hypophosphatasia is enzyme replacement therapy; however the development of a new gene therapy drug, ARU-2801, may change the landscape forever.

Tunde Peto, Professor of Clinical Ophthalmology at Queen’s University Belfast, describes the symptoms, causes and treatments for age-related macular degeneration and how the prevalence of the disease could be reduced.

Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.

Professor Alan Boyd explains the science behind gene therapy, the challenges in treating genetic diseases, and current trends in the sector.

A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.

Sonoenhancement with Acoustic Cluster Therapy (ACT®) improves drug delivery to solid tumors, and by that reduces the necessary doses and side effects.

Prof. Michael Schrader at the University of Exeter looks to understand the role of peroxisomes in human health and disease.

Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.

Here, Charisios Tsiairis from Friedrich Miescher Institute for Biomedical Research explores Hydra Regeneration and the genetic programs that make it possible.

Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.

Dr Dipak Panigrahy, M.D., an Assistant Professor at Harvard Medical School looks at killing tumor cells to resolve the cancer epidemic.

Coldwater therapy means exposing the body to cold temperatures by immersing the body in cold water. This might be by cold water swimming or taking cold water showers or baths.

Could medical approaches of stem cell-based therapy, be a tool for corals’ resilience to heat stress? Benyamin Rosental, Principal Investigator, Assistant Professor at Ben Gurion University of the Negev in Israel answers the compelling question here.

Sean Lawler, Associate Professor at Brown University pursues an understanding of cancer through the lens of the molecular and cellular ecosystem and natural selection.

Honeywell's Manufacturing Excellence Platform will revolutionise the digital transformation of the life sciences industry.

Pascale V Guillot, at the University College London, looks toward improving the quality of life for those with Osteogenesis imperfecta, a chronic health condition called brittle bone disease.